aap Implantate received a funding commitment of up to €0.7 million (~USD $0.8 million) for conception and qualification of a human clinical study to support market approval of its antibacterial silver coating technology.
The company still needs approval from the ethics commissions in Germany before the study can begin. Participating physicians have been trained and equipment (silver-coated implants) has been prepared at corresponding clinics.
The grant is part of BMBF’s Health Industry in the Health Research Framework Programme, whereby funding will be offered for projects that fall under “Transferring medical technology solutions into patient care – proving clinical evidence without delay.” The purpose of the program is to introduce small and medium-sized enterprises to changing legal and regulatory conditions and support them in the clinical validation of medical technology solutions.
aap Implantate received a funding commitment of up to €0.7 million (~USD $0.8 million) for conception and qualification of a human clinical study to support market approval of its antibacterial silver coating technology.
aap Implantate received a funding commitment of up to €0.7 million (~USD $0.8 million) for conception and qualification of a human clinical study to support market approval of its antibacterial silver coating technology.
The company still needs approval from the ethics commissions in Germany before the study can begin. Participating physicians have been trained and equipment (silver-coated implants) has been prepared at corresponding clinics.
The grant is part of BMBF’s Health Industry in the Health Research Framework Programme, whereby funding will be offered for projects that fall under “Transferring medical technology solutions into patient care – proving clinical evidence without delay.” The purpose of the program is to introduce small and medium-sized enterprises to changing legal and regulatory conditions and support them in the clinical validation of medical technology solutions.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE
ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more
Copy to clipboard 
